Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155116331> ?p ?o ?g. }
- W2155116331 endingPage "1562" @default.
- W2155116331 startingPage "1553" @default.
- W2155116331 abstract "Although remission is the ultimate measure of seizure control in epilepsy, and epilepsy syndrome should largely determine this outcome, little is known about the relative importance of syndrome versus other factors traditionally examined as predictors of remission or of relapse after remission. The purpose of this study was to examine remission and relapse with respect to the epilepsy syndrome and other factors traditionally considered with respect to seizure outcome.A prospectively identified cohort of 613 children with newly diagnosed epilepsy was assembled and is actively being followed to determine seizure outcomes. Epilepsy syndrome and etiology were classified at diagnosis and again 2 years later. Remission was defined as 2 years completely seizure-free, and relapse as the recurrence of seizures after remission. Multivariable analysis was performed with the Cox proportional hazards model.Five hundred ninety-four of the original 613 children were followed > or = 2 years (median follow-up, 5 years). Remission occurred in 442 (74%), of whom 107 (24%) relapsed. On multivariable analysis, idiopathic generalized syndromes and age at onset between 5 and 9 years were associated with a substantially increased remission rate, whereas remote symptomatic etiology, family history of epilepsy, seizure frequency, and slowing on the initial EEG were associated with a decreased likelihood of attaining remission. Young onset age (<1 year) and seizure type were not important after adjustment for these predictors. Relapses occurred more often in association with focal slowing on the initial EEG and with juvenile myoclonic epilepsy. Benign rolandic epilepsy and age at onset <1 year were associated with markedly lower risks of relapse. About one fourth of relapses were apparently spontaneous while the child was taking medication with good compliance, and more than half occurred in children who were tapering or had fully stopped medication.A large proportion of children with epilepsy remit. Symptomatic etiology, family history, EEG slowing, and initial seizure frequency negatively influence, and age 5-9 years and idiopathic generalized epilepsy positively influence the probability of entering remission. Factors that most influence relapse tend to be different from those that influence remission." @default.
- W2155116331 created "2016-06-24" @default.
- W2155116331 creator A5015157558 @default.
- W2155116331 creator A5041438947 @default.
- W2155116331 creator A5045461985 @default.
- W2155116331 creator A5061990721 @default.
- W2155116331 creator A5081017140 @default.
- W2155116331 creator A5087848664 @default.
- W2155116331 creator A5089942726 @default.
- W2155116331 date "2001-12-01" @default.
- W2155116331 modified "2023-10-16" @default.
- W2155116331 title "Two‐Year Remission and Subsequent Relapse in Children with Newly Diagnosed Epilepsy" @default.
- W2155116331 cites W1949725482 @default.
- W2155116331 cites W1974622048 @default.
- W2155116331 cites W1983352091 @default.
- W2155116331 cites W1994185280 @default.
- W2155116331 cites W1998116658 @default.
- W2155116331 cites W2007792193 @default.
- W2155116331 cites W2035277224 @default.
- W2155116331 cites W2036500962 @default.
- W2155116331 cites W2036951135 @default.
- W2155116331 cites W2039282175 @default.
- W2155116331 cites W2044699395 @default.
- W2155116331 cites W2045866274 @default.
- W2155116331 cites W2049800034 @default.
- W2155116331 cites W2057836110 @default.
- W2155116331 cites W2074783576 @default.
- W2155116331 cites W2076993158 @default.
- W2155116331 cites W2077941638 @default.
- W2155116331 cites W2090454621 @default.
- W2155116331 cites W2090590886 @default.
- W2155116331 cites W2093933005 @default.
- W2155116331 cites W2095218499 @default.
- W2155116331 cites W2102849835 @default.
- W2155116331 cites W2119611525 @default.
- W2155116331 cites W2126601160 @default.
- W2155116331 cites W2137450015 @default.
- W2155116331 cites W2138413472 @default.
- W2155116331 cites W2328026908 @default.
- W2155116331 cites W2605864756 @default.
- W2155116331 cites W4236676256 @default.
- W2155116331 cites W4239594659 @default.
- W2155116331 cites W4248646554 @default.
- W2155116331 cites W4248786607 @default.
- W2155116331 cites W2304530599 @default.
- W2155116331 doi "https://doi.org/10.1046/j.1528-1157.2001.21101.x" @default.
- W2155116331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11879366" @default.
- W2155116331 hasPublicationYear "2001" @default.
- W2155116331 type Work @default.
- W2155116331 sameAs 2155116331 @default.
- W2155116331 citedByCount "114" @default.
- W2155116331 countsByYear W21551163312012 @default.
- W2155116331 countsByYear W21551163312013 @default.
- W2155116331 countsByYear W21551163312014 @default.
- W2155116331 countsByYear W21551163312015 @default.
- W2155116331 countsByYear W21551163312016 @default.
- W2155116331 countsByYear W21551163312017 @default.
- W2155116331 countsByYear W21551163312018 @default.
- W2155116331 countsByYear W21551163312019 @default.
- W2155116331 countsByYear W21551163312020 @default.
- W2155116331 countsByYear W21551163312021 @default.
- W2155116331 countsByYear W21551163312022 @default.
- W2155116331 countsByYear W21551163312023 @default.
- W2155116331 crossrefType "journal-article" @default.
- W2155116331 hasAuthorship W2155116331A5015157558 @default.
- W2155116331 hasAuthorship W2155116331A5041438947 @default.
- W2155116331 hasAuthorship W2155116331A5045461985 @default.
- W2155116331 hasAuthorship W2155116331A5061990721 @default.
- W2155116331 hasAuthorship W2155116331A5081017140 @default.
- W2155116331 hasAuthorship W2155116331A5087848664 @default.
- W2155116331 hasAuthorship W2155116331A5089942726 @default.
- W2155116331 hasBestOaLocation W21551163311 @default.
- W2155116331 hasConcept C118552586 @default.
- W2155116331 hasConcept C126322002 @default.
- W2155116331 hasConcept C137627325 @default.
- W2155116331 hasConcept C142724271 @default.
- W2155116331 hasConcept C15744967 @default.
- W2155116331 hasConcept C187212893 @default.
- W2155116331 hasConcept C201903717 @default.
- W2155116331 hasConcept C204787440 @default.
- W2155116331 hasConcept C2776434150 @default.
- W2155116331 hasConcept C2777767895 @default.
- W2155116331 hasConcept C2778186239 @default.
- W2155116331 hasConcept C2778734009 @default.
- W2155116331 hasConcept C2779134260 @default.
- W2155116331 hasConcept C2779814861 @default.
- W2155116331 hasConcept C2779979230 @default.
- W2155116331 hasConcept C522805319 @default.
- W2155116331 hasConcept C71924100 @default.
- W2155116331 hasConcept C72563966 @default.
- W2155116331 hasConceptScore W2155116331C118552586 @default.
- W2155116331 hasConceptScore W2155116331C126322002 @default.
- W2155116331 hasConceptScore W2155116331C137627325 @default.
- W2155116331 hasConceptScore W2155116331C142724271 @default.
- W2155116331 hasConceptScore W2155116331C15744967 @default.
- W2155116331 hasConceptScore W2155116331C187212893 @default.
- W2155116331 hasConceptScore W2155116331C201903717 @default.
- W2155116331 hasConceptScore W2155116331C204787440 @default.